Rationale: Chlorine gas (Cl) is a potent oxidant and trigger of irritant induced asthma. We explored NF-E2-related factor 2 (Nrf2)-dependent mechanisms in the asthmatic response to Cl, using Nrf2-deficient mice, buthionine sulfoximine (BSO), an inhibitor of glutathione (GSH) synthesis and sulforaphane (SFN), a phytochemical regulator of Nrf2.

Methods: Airway inflammation and airway hyperresponsiveness (AHR) were assessed 24 and 48h after a 5-min nose-only exposure to 100ppm Cl of Nrf2-deficient and wild type Balb/C mice treated with BSO or SFN. Animals were anesthetized, paralyzed and mechanically ventilated (FlexiVent™) and challenged with aerosolized methacholine. Bronchoalveolar lavage (BAL) was performed and lung tissues were harvested for assessment of gene expression.

Results: Cl exposure induced a robust AHR and an intense neutrophilic inflammation that, although similar in Nrf2-deficient mice and wild-type mice at 24h after Cl exposure, were significantly greater at 48h post exposure in Nrf2-deficient mice. Lung GSH and mRNA for Nrf2-dependent phase II enzymes (NQO-1 and GPX2) were significantly lower in Nrf2-deficient than wild-type mice after Cl exposure. BSO reduced GSH levels and promoted Cl-induced airway inflammation in wild-type mice, but not in Nrf2-deficient mice, whereas SFN suppressed Cl-induced airway inflammation in wild-type but not in Nrf2-deficient mice. AHR was not affected by either BSO or SFN at 48h post Cl exposure.

Conclusions: Nrf2-dependent phase II enzymes play a role in the resolution of airway inflammation and AHR after Cl exposure. Moderate deficiency of GSH affects the magnitude of acute inflammation but not AHR.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2016.11.017DOI Listing

Publication Analysis

Top Keywords

nrf2-deficient mice
20
airway inflammation
16
wild-type mice
12
mice
10
inflammation airway
8
airway hyperresponsiveness
8
bso sfn
8
48h post
8
nrf2-dependent phase
8
phase enzymes
8

Similar Publications

Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2.

Leukemia

November 2024

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

Chronic graft-versus-host disease (cGVHD), characterized by chronic tissue inflammation and fibrosis involving multiple organs, remains a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Dimethyl fumarate (DMF) is an anti-inflammatory drug approved for the treatment of multiple sclerosis and psoriasis. We previously reported that DMF effectively inhibits acute GVHD (aGVHD) while preserving the graft-versus-leukemia effect.

View Article and Find Full Text PDF
Article Synopsis
  • Millions get influenza yearly, often complicated by secondary bacterial pneumonia, with inflammatory cytokines playing a role in susceptibility.
  • Nrf2, a key regulator of antioxidant and inflammatory responses, was studied using mice models to analyze its impact on influenza and Staphylococcus aureus superinfection.
  • Results showed that Nrf2 deficiency led to reduced flu severity and increased bacterial load, while enhancing regulatory T cell responses that improved survival time, despite the higher bacterial presence.
View Article and Find Full Text PDF

Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8 T and CAR-T cells.

Mol Ther

November 2024

Department of Anatomy, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea; Department of Convergence Medical Science, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea; PNU GRAND Convergence Medical Science Education Research Center, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea. Electronic address:

Article Synopsis
  • * The study found that Nrf2, a protein that responds to ROS, is linked to suppressed anti-tumor responses in CTLs; Nrf2 knockout mice showed better tumor control when T cells were depleted.
  • * Nrf2-deficient CTLs displayed enhanced survival and function in the TME, suggesting that targeting Nrf2 could improve T-cell immunotherapy effectiveness against solid tumors.
View Article and Find Full Text PDF

Asthma is a heterogeneous disease that can be broadly classified into type 2, which is primarily steroid-sensitive and eosinophilic, and non-type 2, which is primarily steroid-resistant and neutrophilic. While the mechanisms leading to the development of molecular-targeted therapies for type 2 asthma are being elucidated, much remains to be learned about non-type 2 asthma. To investigate the role of oxidative stress in refractory allergic airway inflammation, we compared asthma models generated by immunizing wild-type and nuclear factor erythroid-2-related factor 2 (Nrf2)-deficient mice with the house dust mite antigen.

View Article and Find Full Text PDF
Article Synopsis
  • * Research with mice and cultured cells shows that Uro A increases mucin 2 expression and thickens colonic mucus without affecting tight junctions, which are crucial for maintaining barrier integrity.
  • * Uro A treatment also reduces gut permeability and inflammation, promotes beneficial bacteria, and works through specific signaling pathways (Nrf2 and AhR) to enhance mucus secretion and support intestinal health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!